EXACT Sciences Corporation (EXAS) — Cash Flow Reinvestment Rate

Latest as of December 2025: 1.51x

EXACT Sciences Corporation (EXAS) has a Cash Flow Reinvestment Rate of 1.51x as of December 2025, reinvesting $228.60 Million (capex $31.24 Million plus investments $197.36 Million) from operating cash flow of $151.69 Million. Explore EXACT Sciences Corporation capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.51x
(Capex + Investments) / Operating CF

Total Reinvested

$228.60 Million
Capex + Investments

Operating Cash Flow

$151.69 Million
USD

Capital Expenditures

$31.24 Million
USD

EXACT Sciences Corporation Cash Flow Reinvestment Rate (2020–2025)

Historical reinvestment intensity for EXACT Sciences Corporation across 4 annual periods. Also explore total assets of EXACT Sciences Corporation for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for EXACT Sciences Corporation (2020–2025)

Year-by-year capital reinvestment analysis for EXACT Sciences Corporation. For live market cap and broader valuation context, see EXACT Sciences Corporation stock valuation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 1.04x $511.17 Million $491.44 Million $134.66 Million ▼ -62.1%
2024 2.75x $578.14 Million $210.54 Million $135.99 Million ▲ +146.6%
2023 1.11x $173.87 Million $156.12 Million $124.19 Million ▼ -46.4%
2020 2.08x $283.58 Million $136.48 Million $64.35 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow